Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule

被引：0
|
作者：
Agustin A. Garcia
Mahesh Pujari
Susan Jeffers
Syma Iqbal
Heinz-Josef Lenz
Paul Beringer
Stan Louie
机构：
[1] University of Southern California,Norris Comprehensive Cancer Center, Keck School of Medicine
[2] University of Southern California,School of Pharmacy
[3] Women’s Cancer Research Institute,Cedars Sinai Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2005年 / 56卷
关键词：
Phase I; Clinical trial; Pharmacokinetics; Docetaxel; Irinotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 82
页数：7
相关论文
共 50 条
  • [1] Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule
    Garcia, AA
    Pujari, M
    Jeffers, S
    Iqbal, S
    Lenz, HJ
    Beringer, P
    Louie, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (01) : 75 - 82
  • [2] A phase I study of irinotecan administered on a weekly schedule in pediatric patients
    Bomgaars, L
    Kerr, J
    Berg, S
    Kuttesch, J
    Klenke, R
    Blaney, SM
    PEDIATRIC BLOOD & CANCER, 2006, 46 (01) : 50 - 55
  • [3] PHASE-I AND PHARMACOKINETIC STUDY OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, ADMINISTERED ON A WEEKLY SCHEDULE IN CANCER-PATIENTS
    DEFORNI, M
    BUGAT, R
    CHABOT, GG
    CULINE, S
    EXTRA, JM
    GOUYETTE, A
    MADELAINE, I
    MARTY, ME
    MATHIEUBOUE, A
    CANCER RESEARCH, 1994, 54 (16) : 4347 - 4354
  • [4] Phase I clinical trial of weekly combined topotecan and irinotecan
    Lokich, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (04): : 336 - 340
  • [5] PHASE-I TRIAL AND BIOCHEMICAL EVALUATION OF TIAZOFURIN ADMINISTERED ON A WEEKLY SCHEDULE
    MELINK, TJ
    SAROSY, G
    HANAUSKE, AR
    PHILLIPS, JL
    BAYNE, JH
    GREVER, MR
    JAYARAM, HN
    VONHOFF, DD
    SELECTIVE CANCER THERAPEUTICS, 1990, 6 (01): : 51 - 61
  • [6] Pharmacokinetic (pk) and safety study of irinotecan (Ir) and capecitabine (Cp) administered on a weekly schedule.
    Gollamudi, R.
    Baker, S. D.
    Desai, K. K.
    Chaudhary, I.
    Kaubisch, A.
    Camacho, F. J.
    Einstein, M.
    Goldberg, G.
    Goel, S.
    Mani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 94S - 94S
  • [7] Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer
    Hainsworth, JD
    Burris, HA
    Erland, JB
    Thomas, M
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2164 - 2168
  • [8] Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancer
    Bleickardt, E
    Argiris, A
    Rich, R
    Blum, K
    McKeon, A
    Tara, H
    Zelterman, D
    Burtness, B
    Davies, MJ
    Murren, JR
    CANCER BIOLOGY & THERAPY, 2002, 1 (06) : 646 - 651
  • [9] Phase I trial of weekly irinotecan plus docetaxel in patients with advanced solid tumors.
    Font, A
    Sánchez, JM
    Guillot, M
    Abad, A
    Taron, M
    Margelí, M
    Barnadas, A
    Rosell, R
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
  • [10] Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer
    Bhargava, P
    Marshall, JL
    Fried, K
    Williams, M
    Lefebvre, P
    Dahut, W
    Hanfelt, J
    Gehan, E
    Figuera, M
    Hawkins, MJ
    Rizvi, NA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (02) : 95 - 103
12345